Products & Services


Nanopore sequencing offers advantages in all areas of research. Our offering includes DNA sequencing, as well as RNA and gene expression analysis and future technology for analysing proteins.

Learn about applications
View all Applications
News Explore
Contact Get started

Oxford Nanopore Successfully Defends PacBio lawsuit

Thu 8th February 2018

In November 2016, PacBio filed a Complaint with the International Trade Commission (“ITC”) alleging that Oxford Nanopore infringed two of PacBio’s patents and seeking to prevent Oxford Nanopore from selling its product in the United States. 

Today, the ITC Commission has made a Final Determination affirming the Administrative Judge’s decision that Oxford Nanopore has not infringed PacBio’s patents. The ITC Commission also found that there has been no violation of 19 U.S.C. §1337 and terminated the ITC investigation.

Gordon Sanghera, CEO of Oxford Nanopore, said: “We are pleased that Pacific Biosciences has failed, in this action, to prevent Americans choosing and benefiting from Nanopore single molecule, real-time DNA sequencing”.

Open a chat to talk to our sales team